Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
Press Release

Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596

HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing           Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales royalties SHANGHAI, Sept. 29, 2026 /PRNewswire/ — Hengrui Pharma (600276.SH; 01276.HK) today announced that it has entered into a license agreement with Novo Nordisk (Novo) for HRS-1596, a phase I-ready glucagon-like peptide-1 receptor (GLP-1R) […]

Read More
Zoomlion Signs US0 Million Credit Insurance Policy and Initial US Million Non-Recourse Factoring Agreement
Press Release

Zoomlion Signs US$300 Million Credit Insurance Policy and Initial US$50 Million Non-Recourse Factoring Agreement

SHANGHAI, Sept. 29, 2026 /PRNewswire/ — Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") signed a US$300 million portfolio credit insurance policy and an initial US$50 million non-recourse factoring agreement at the Zoomlion 2026 Global Financial Partners Summit and Signing Ceremony in Shanghai on September 11, establishing a tiered insurance-and-financing framework for overseas installment receivables […]

Read More
iRegene Therapeutics's NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa
Press Release

iRegene Therapeutics's NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

– Following its Parkinson’s disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. CHENGDU, China, Sept. 29, 2026 /PRNewswire/ — iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its investigational cell therapy NouvSight001 has received clearance […]

Read More
Sensitive Choice-Certified Coway Airmega Offers Trusted Relief for Spring Allergy Season
Press Release

Sensitive Choice-Certified Coway Airmega Offers Trusted Relief for Spring Allergy Season

Highlights Sensitive Choice certified Airmega 350 for open-plan living alongside 11-time Wirecutter winner Airmega Mighty Offers up to 44% off on Amazon Australia Prime Big Deal Days to support 2.8 million Australians living with respiratory conditions SYDNEY, Sept. 29, 2026 /PRNewswire/ — Coway, South Korea’s leading wellness tech company, today announced a major spring allergen […]

Read More
AsiaPay Pilot Launches Voice Pay for merchants in Asia
Press Release

AsiaPay Pilot Launches Voice Pay for merchants in Asia

An AI-Powered UI for Smarter Convenient Payments HONG KONG, Sept. 29, 2026 /PRNewswire/ — AsiaPay, a leading digital payment service and technology provider in Asia, announced on 23 September 2026 the pilot  launch of Voice Pay, an AI-powered voice payment experience that lets consumers speak into their mobile device and instruct payment using their preferred payment […]

Read More
Segway Powersports Brings Latin American and Canadian Media and Creators from Factory Floor to Real-World Terrain
Press Release

Segway Powersports Brings Latin American and Canadian Media and Creators from Factory Floor to Real-World Terrain

CHANGZHOU, China, Sept. 29, 2026 /PRNewswire/ — Segway Powersports hosted 14 media representatives and creators from Canada, Chile, Peru, Panama, Brazil and Argentina from September 14–19 for the SEGWAY POWERSPORTS CHINA TOUR-2026 LATAM & CANADA EDITION, an immersive program connecting behind-the-scenes manufacturing insights with a full-lineup off-road riding experience. The program began at Segway Powersports’ manufacturing […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.